This WP which includes the Ghana National Drugs Program (GNDP) and the Procurement and Supply Directorate to be coordinated by the Ministry of Health and supported by UHAS, Swiss TPH and an inter sectoral Technical Working Group on evidence synthesis. It will ensure that the necessary institutional capacity is built to conduct HTA on new vaccines, ensuring that national treatment guidelines are updated, and a more efficient and responsive supply chain system is established in preparation for a nationwide scale up of new medical interventions using the malaria vaccine as an entry point.

Work Package Three (WP3) The SAVING project through this work package will strengthen evidence based prioritysetting mechanisms on new technologies including vaccines; improve on mechanisms forintegration of recommendations into national guidelines; build capacity for supply chainresponse to new technologies as well as improve on mechanisms of equipping patients withinformation on new medical technologies.Estimated cost of the work package is Euro 268,067.02

Objectives

The Objectives of this work package are to

  1. Build institutional capacity in and enhance evidence-based decision-making through Health Technology Assessment (HTA) that will establish a system for adding new vaccines to Ghana’s Standard Treatment Guidelines
  2. Strengthen human resource capacity in the procurement and supply chain mechanisms for vaccines and new medical interventions
  3. Identify challenges and improve on mechanisms for the dissemination of information on new medical technologies to patients
Lead Organisation
Work Packages

Team Members

Dr. Martha Gyansa-Lutterodt

Ministry of Health, WP3 Lead

Edith Gavor

Coordinator

Dr. Matilda Aberese-Ako

UHAS Researcher/Embedded Scientist

Dr. Maxwell Dalaba

UHAS Researcher/Embedded Scientist

Dr. Mustapha Immurana

UHAS Researcher/Embedded Scientist

Dr. Brian Asare

Coordinator

Dr. Joycelyn Azeez

Coordinator

Festus Korang

Coordinator

Emmanuella Abassah-Konadu

Coordinator